These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27529942)

  • 1. [THERAPEUTIC AND DIETARY CORRECTION OF PROTEIN-ENERGY DEFICIENCY WITH A DRY PROTEIN COMPOSITE FORMULA IN PATIENTS WITH PULMONARY TUBERCULOSIS IN A TUBERCULOSIS HOSPITAL].
    Tuberk Biolezni Legkih; 2010; (2):40-3. PubMed ID: 27529942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CORRECTION OF METABOLIC DISTURBANCES IN PATIENTS WITH PULMONARY TUBERCULOSIS AND CONCOMITANT DISEASES].
    Tuberk Biolezni Legkih; 2010; (2):49-53. PubMed ID: 27529944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of magnetic and ultrasound therapy on clinical manifestations and general parameters of efficiency in the treatment of pulmonary tuberculosis].
    Savchenko VI; Samosiuk IZ
    Lik Sprava; 2004; (7):41-6. PubMed ID: 15724612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CLINICAL AND X-RAY CHARACTERISTICS AND THERAPEUTIC EFFICIENCY IN PATIENTS WITH INFILTRATIVE PULMONARY TUBERCULOSIS AND VARIOUS AUTONOMIC HOMEOSTATIC CHANGES].
    Tuberk Biolezni Legkih; 2010; (5):31-4. PubMed ID: 27534038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous chemotherapy and galvanization of damaged lung regions in patients with newly diagnosed pulmonary tuberculosis].
    Strelis AK; Blinov VIu; Andreev IG
    Probl Tuberk; 1991; (12):24-6. PubMed ID: 1803367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EFFERENT THERAPY IN THE TREATMENT OF PATIENTS WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS].
    Tuberk Biolezni Legkih; 2010; (3):28-33. PubMed ID: 27529955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [THE FREQUENCY OF ADVERSE REACTIONS TO ANTITUBERCULOUS AGENTS IN FIRST DETECTED PATIENTS OLDER THAN 18 YEARS WITH PULMONARY TUBERCULOSIS AND THE FACTORS INFLUENCING THEIR DEVELOPMENT].
    Tuberk Biolezni Legkih; 2010; (2):44-8. PubMed ID: 27529943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae.
    Wang Z; Ge Z; Jin W; Qiao Y; Ding H; Zhao H; Lin Z; Chen J; Yang W
    Spine J; 2007; 7(6):671-81. PubMed ID: 17998127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania.
    PrayGod G; Range N; Faurholt-Jepsen D; Jeremiah K; Faurholt-Jepsen M; Aabye MG; Jensen L; Jensen AV; Grewal HM; Magnussen P; Changalucha J; Andersen AB; Friis H
    Br J Nutr; 2012 Jan; 107(2):263-71. PubMed ID: 21729372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K; Wada M
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
    Savula MM; Kravchenko NS
    Probl Tuberk; 2001; (8):26-8. PubMed ID: 11767385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ascorbic acid and emoxypin on the efficiency of complex chemotherapy for infiltrative pulmonary tuberculosis].
    Volchegorskiĭ IA; Novoselov PN; Astakhova TV
    Ter Arkh; 2009; 81(11):21-4. PubMed ID: 20141008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumoconiosis and mycobacterial infection].
    Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of chemotherapy of primary forms of pulmonary tuberculosis in adolescents].
    Firsova VA; Ovsiankina ES; Ianchevskaia AA
    Probl Tuberk; 1990; (11):21-3. PubMed ID: 2290807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organization of in- and outpatient treatment of new cases of destructive pulmonary tuberculosis].
    Ursov IG; Naryshkina SL; Krasnov VA; Potashova VA; Borovinskaia TA; Kudelia OA; Volkova ZA
    Probl Tuberk; 1997; (4):4-5. PubMed ID: 9333817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of causes of death in patients with pulmonary tuberculosis].
    Takahara M
    Kekkaku; 2004 Dec; 79(12):711-6. PubMed ID: 15782616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.